{
  "trial_id": "NCT01885559",
  "trial_group": "hypertension",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, Gender, Baseline GFR, Blood Pressure, Diagnosis of ADPKD, Serum Potassium Levels, Urine Albumin-to-Creatinine Ratio, Fasting Serum Glucose, Random Non-Fasting Glucose, History of Hypertension Treatment, History of Angioneurotic Edema, Use of ACE-I or ARB, Use of \u03b2-blocker or Calcium Channel Blocker, Systemic Illness, Hospitalization History, Life Expectancy, History of Non-Compliance, Presence of Cerebral Aneurysm, Use of Creatine Supplements, Congenital Absence of a Kidney, Known Allergies.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Gender"
        ],
        [
          "Chronic Kidney Disease Epidemiology Collaboration (CKD EPI) eGFR (ml/min/m^2)",
          "Baseline GFR"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race (NIH/OMB)",
        "PKD Genotype",
        "Age at Diagnosis of Autosomal Dominant Polycystic Kidney Disease (yrs)",
        "Body Mass Index (kg/m2)",
        "Serum Creatinine (mg/dl)"
      ],
      "remaining_candidate_features": [
        "Blood Pressure",
        "Diagnosis of ADPKD",
        "Serum Potassium Levels",
        "Urine Albumin-to-Creatinine Ratio",
        "Fasting Serum Glucose",
        "Random Non-Fasting Glucose",
        "History of Hypertension Treatment",
        "History of Angioneurotic Edema",
        "Use of ACE-I or ARB",
        "Use of \u03b2-blocker or Calcium Channel Blocker",
        "Systemic Illness",
        "Hospitalization History",
        "Life Expectancy",
        "History of Non-Compliance",
        "Presence of Cerebral Aneurysm",
        "Use of Creatine Supplements",
        "Congenital Absence of a Kidney",
        "Known Allergies"
      ]
    },
    "processed-gen-response": "Age, Gender, Baseline GFR, Blood Pressure, Diagnosis of ADPKD, Serum Potassium Levels, Urine Albumin-to-Creatinine Ratio, Fasting Serum Glucose, Random Non-Fasting Glucose, History of Hypertension Treatment, History of Angioneurotic Edema, Use of ACE-I or ARB, Use of \u03b2-blocker or Calcium Channel Blocker, Systemic Illness, Hospitalization History, Life Expectancy, History of Non-Compliance, Presence of Cerebral Aneurysm, Use of Creatine Supplements, Congenital Absence of a Kidney, Known Allergies."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Baseline eGFR, Blood Pressure, Serum Potassium, Urine Albumin-to-Creatinine Ratio, Diabetes Status, Use of Antihypertensive Medication, Family History of ADPKD,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Chronic Kidney Disease Epidemiology Collaboration (CKD EPI) eGFR (ml/min/m^2)",
          "Baseline eGFR"
        ],
        [
          "Serum Potassium",
          "Serum Potassium"
        ],
        [
          "Urine Albumin-to-Creatinine Ratio",
          "Urine Albumin-to-Creatinine Ratio"
        ]
      ],
      "remaining_reference_features": [
        "PKD Genotype",
        "Age at Diagnosis of Autosomal Dominant Polycystic Kidney Disease (yrs)",
        "Body Mass Index (kg/m2)",
        "Serum Creatinine (mg/dl)"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Blood Pressure",
        "Diabetes Status",
        "Use of Antihypertensive Medication",
        "Family History of ADPKD"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Baseline eGFR, Blood Pressure, Serum Potassium, Urine Albumin-to-Creatinine Ratio, Diabetes Status, Use of Antihypertensive Medication, Family History of ADPKD"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Estimated Glomerular Filtration Rate, Urine Albumin-to-Creatinine Ratio, Serum Potassium, History of Hypertension, History of Diabetes, Family History of ADPKD.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Body Mass Index (kg/m2)",
          "Body Mass Index"
        ],
        [
          "Chronic Kidney Disease Epidemiology Collaboration (CKD EPI) eGFR (ml/min/m^2)",
          "Estimated Glomerular Filtration Rate"
        ]
      ],
      "remaining_reference_features": [
        "PKD Genotype",
        "Age at Diagnosis of Autosomal Dominant Polycystic Kidney Disease (yrs)",
        "Serum Creatinine (mg/dl)"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Urine Albumin-to-Creatinine Ratio",
        "Serum Potassium",
        "History of Hypertension",
        "History of Diabetes",
        "Family History of ADPKD."
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Estimated Glomerular Filtration Rate, Urine Albumin-to-Creatinine Ratio, Serum Potassium, History of Hypertension, History of Diabetes, Family History of ADPKD."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), systolic and diastolic blood pressure, estimated glomerular filtration rate (eGFR), serum creatinine, serum potassium, spot urine albumin-to-creatinine ratio, fasting serum glucose, history of hypertension, history of diabetes, history of cardiovascular disease, smoking status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Body Mass Index (kg/m2)",
          "body mass index (BMI)"
        ],
        [
          "Serum Creatinine (mg/dl)",
          "serum creatinine"
        ],
        [
          "Chronic Kidney Disease Epidemiology Collaboration (CKD EPI) eGFR (ml/min/m^2)",
          "estimated glomerular filtration rate (eGFR)"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "PKD Genotype",
        "Age at Diagnosis of Autosomal Dominant Polycystic Kidney Disease (yrs)"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "systolic and diastolic blood pressure",
        "serum potassium",
        "spot urine albumin-to-creatinine ratio",
        "fasting serum glucose",
        "history of hypertension",
        "history of diabetes",
        "history of cardiovascular disease",
        "smoking status"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, body mass index (BMI), systolic and diastolic blood pressure, estimated glomerular filtration rate (eGFR), serum creatinine, serum potassium, spot urine albumin-to-creatinine ratio, fasting serum glucose, history of hypertension, history of diabetes, history of cardiovascular disease, smoking status."
  }
}